Clearside BioMedical Growth, Revenue, Number of Employees and Funding


Atlanta, GA USA
Total Funding:$95.3M
Lead Investor(s):RusnanoMedInvest

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Clearside BioMedical's estimated revenue is currently $11.5M per year.
  • Clearside BioMedical received $20.0M in venture funding in December 2015.
  • Clearside BioMedical's estimated revenue per employee is $187820
  • Clearside BioMedical's total funding is $95.3M.

Employee Data

  • Clearside BioMedical has 61 Employees.
  • Clearside BioMedical grew their employee count by 27% last year.
  • Clearside BioMedical currently has 1 job openings.

Executive Contacts

Daniel WhitePresident and CEO
Rafael AndinoVice President, Engineering & Manufacturing
Leslie ZacksGeneral Counsel and Chief Compliance Officer
Andrew AlexanderSenior Director, IT
Viral KansaraVice President, Discovery
Janet StanishSr. Director, Quality Assurance and Compliance
Thai NguyenSr Director, CMC
Lori HallSenior Director, Quality Engineering and Supplier Quality
Barbara BauschkaSenior Director, Regulatory Operations
Kathleen BillmanSenior Director, Clinical Trial Management

What Is Clearside BioMedical?

Clearside Biomedical, Inc., is a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases. Clearside's proprietary suprachoroidal treatment approach offers unprecedented access to the back of the eye where sight threatening disease often occurs. The company's unique platform for eye disease treatments is inherently flexible and intended to work with established medicines, new formulations of medicines, as well as future innovations. Clearside's pipeline includes advanced and pre-clinical product candidates in diseases where macular edema is a common complication, including uveitis, retinal vein occlusion, DME and wet age-related macular degeneration. Clearside's most advanced program is in non-infectious uveitis and it expects to file a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for use of suprachoroidal CLS-TA in non-infectious uveitis by the end of 2018. Clearside is headquartered in Alpharetta, GA. For more information, please visit

keywords:Biotechnology,Cleantech,Healthcare,Medical Devices,Pharmaceuticals,Wind Power


Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Envision Commun...
Avion Pharmaceu...
Peachtree Biore...
Premier Kids Ca...
Clearside BioMe...
S Phase
Acella Pharmace...
Sebela Pharmace...
Relief Pharmaci...

Clearside BioMedical News

08/22/2019 - Clearside Biomedical Provides New Drug Application Update ...

ALPHARETTA, Ga., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq:CLSD), a biopharmaceutical company ...

09/04/2019 - Clearside Biomedical Shares Rebound On Microinjector ...

Clearside Biomedical Inc (NASDAQ: CLSD) shares — which came under intense selling pressure in late August after the company hinted at a ...

09/05/2019 - Clearside Biomedical, Regenxbio ink sales deal for gene ...

Clearside Biomedical (NSDQ:CLSD) has agreed to grant Regenxbio (NSDQ:RGNX) the option to an exclusive worldwide license to sell ...

Clearside BioMedical Funding

DateAmountRoundLead InvestorsReference

Clearside BioMedical Executive Hires

2012-10-30Charles DeignanChief Financial OfficerArticle
2013-02-26Rafael V. AndinoVP Product DevelopmentArticle
2013-03-05Stephen H. LannVP Commercial OperationsArticle
2013-08-06Glenn Noronha,EVP R/DArticle
2017-01-05Richard BeckmanChief Medical OfficerArticle
2018-07-12Carol HoangVP Medical AffairsArticle
2018-09-12Leslie ZacksGeneral Counsel and Chief Compliance OfficerArticle
2018-09-13Viral KansaraVP DiscoveryArticle
2018-10-22Thomas CrawfordVice President, Supply ChaiArticle
2018-10-26Thomas CiullaChief Medical OfficerArticle